Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

118.6  -0.1 (-0.08%)

Fundamental Rating

6

BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 53 industry peers in the Health Care Equipment & Supplies industry. BIM gets an excellent profitability rating and is at the same time showing great financial health properties. BIM has a correct valuation and a medium growth rate. These ratings would make BIM suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
In the past 5 years BIM has always been profitable.
BIM had a positive operating cash flow in each of the past 5 years.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.49%, BIM belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.28%, BIM is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
BIM has a Return On Invested Capital of 9.33%. This is amongst the best in the industry. BIM outperforms 85.19% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 8.25%.
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROIC 9.33%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BIM has a better Profit Margin (10.86%) than 79.63% of its industry peers.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
Looking at the Operating Margin, with a value of 14.79%, BIM belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
In the last couple of years the Operating Margin of BIM has grown nicely.
Looking at the Gross Margin, with a value of 55.66%, BIM is in line with its industry, outperforming 53.70% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
Compared to 5 years ago, BIM has less shares outstanding
The debt/assets ratio for BIM has been reduced compared to a year ago.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 6.78 indicates that BIM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.78, BIM belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
BIM has a Debt to FCF ratio of 1.53. This is amongst the best in the industry. BIM outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BIM is not too dependend on debt financing.
BIM has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. BIM outperforms 87.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 6.78
ROIC/WACC1.18
WACC7.92%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

BIM has a Current Ratio of 2.20. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
BIM's Current ratio of 2.20 is fine compared to the rest of the industry. BIM outperforms 66.67% of its industry peers.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM has a Quick ratio of 1.29. This is in the better half of the industry: BIM outperforms 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

The Earnings Per Share is expected to grow by 12.79% on average over the next years. This is quite good.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 6.33% on average per year.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y12.79%
Revenue Next Year7.97%
Revenue Next 2Y7.02%
Revenue Next 3Y7.98%
Revenue Next 5Y6.33%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.73, the valuation of BIM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 66.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.18, BIM is valued at the same level.
With a Price/Forward Earnings ratio of 25.57, BIM can be considered very expensive at the moment.
BIM's Price/Forward Earnings is on the same level as the industry average.
BIM is valuated rather expensively when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.73
Fwd PE 25.57
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

77.78% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than the industry average as 64.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 43.66
EV/EBITDA 15.63
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
BIM's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.53
PEG (5Y)2.82
EPS Next 2Y16.12%
EPS Next 3Y15.21%

4

5. Dividend

5.1 Amount

BIM has a yearly dividend return of 0.76%, which is pretty low.
BIM's Dividend Yield is a higher than the industry average which is at 2.47.
With a Dividend Yield of 0.76, BIM pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years0
Div Non Decr Years6
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

23.18% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (5/2/2025, 7:00:00 PM)

118.6

-0.1 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-07 2025-03-07/bmo
Earnings (Next)05-15 2025-05-15
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.04B
Analysts76.67
Price Target128.81 (8.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.56%
PT rev (3m)3.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)1.48%
Valuation
Industry RankSector Rank
PE 30.73
Fwd PE 25.57
P/S 3.53
P/FCF 43.66
P/OCF 21.04
P/B 3.34
P/tB 4.71
EV/EBITDA 15.63
EPS(TTM)3.86
EY3.25%
EPS(NY)4.64
Fwd EY3.91%
FCF(TTM)2.72
FCFY2.29%
OCF(TTM)5.64
OCFY4.75%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.53
PEG (5Y)2.82
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROCE 12.7%
ROIC 9.33%
ROICexc 9.83%
ROICexgc 13.6%
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
FCFM 8.08%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA 0.39
Cap/Depr 106.34%
Cap/Sales 8.69%
Interest Coverage 250
Cash Conversion 73.01%
Profit Quality 74.39%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 6.78
F-Score7
WACC7.92%
ROIC/WACC1.18
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y12.79%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.97%
Revenue Next 2Y7.02%
Revenue Next 3Y7.98%
Revenue Next 5Y6.33%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.85%
EBIT Next 3Y28.18%
EBIT Next 5Y18.65%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%